Master Protocol to Collect Long Term Safety Data on Patients Treated with a Fate Therapeutics Engineered Cell Product Where a University of Minnesota Faculty Member is the IND Sponsor
|Effective start/end date
|1/21/22 → 1/31/27
- FATE THERAPEUTICS, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.